Cargando…

Modified Snake α-Neurotoxin Averts β-Amyloid Binding to α7 Nicotinic Acetylcholine Receptor and Reverses Cognitive Deficits in Alzheimer’s Disease Mice

Alzheimer’s disease (AD) is the most common cause of senile dementia and one of the greatest medical, social, and economic challenges. According to a dominant theory, amyloid-β (Aβ) peptide is a key AD pathogenic factor. Aβ-soluble species interfere with synaptic functions, aggregate gradually, form...

Descripción completa

Detalles Bibliográficos
Autores principales: Fonar, Gennadiy, Polis, Baruh, Sams, Dev Sharan, Levi, Almog, Malka, Assaf, Bal, Natalia, Maltsev, Alexander, Elliott, Evan, Samson, Abraham O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018932/
https://www.ncbi.nlm.nih.gov/pubmed/33417228
http://dx.doi.org/10.1007/s12035-020-02270-0
_version_ 1783674278069141504
author Fonar, Gennadiy
Polis, Baruh
Sams, Dev Sharan
Levi, Almog
Malka, Assaf
Bal, Natalia
Maltsev, Alexander
Elliott, Evan
Samson, Abraham O.
author_facet Fonar, Gennadiy
Polis, Baruh
Sams, Dev Sharan
Levi, Almog
Malka, Assaf
Bal, Natalia
Maltsev, Alexander
Elliott, Evan
Samson, Abraham O.
author_sort Fonar, Gennadiy
collection PubMed
description Alzheimer’s disease (AD) is the most common cause of senile dementia and one of the greatest medical, social, and economic challenges. According to a dominant theory, amyloid-β (Aβ) peptide is a key AD pathogenic factor. Aβ-soluble species interfere with synaptic functions, aggregate gradually, form plaques, and trigger neurodegeneration. The AD-associated pathology affects numerous systems, though the substantial loss of cholinergic neurons and α7 nicotinic receptors (α7AChR) is critical for the gradual cognitive decline. Aβ binds to α7AChR under various experimental settings; nevertheless, the functional significance of this interaction is ambiguous. Whereas the capability of low Aβ concentrations to activate α7AChR is functionally beneficial, extensive brain exposure to high Aβ concentrations diminishes α7AChR activity, contributes to the cholinergic deficits that characterize AD. Aβ and snake α-neurotoxins competitively bind to α7AChR. Accordingly, we designed a chemically modified α-cobratoxin (mToxin) to inhibit the interaction between Aβ and α7AChR. Subsequently, we examined mToxin in a set of original in silico, in vitro, ex vivo experiments, and in a murine AD model. We report that mToxin reversibly inhibits α7AChR, though it attenuates Aβ-induced synaptic transmission abnormalities, and upregulates pathways supporting long-term potentiation and reducing apoptosis. Remarkably, mToxin demonstrates no toxicity in brain slices and mice. Moreover, its chronic intracerebroventricular administration improves memory in AD-model animals. Our results point to unique mToxin neuroprotective properties, which might be tailored for the treatment of AD. Our methodology bridges the gaps in understanding Aβ-α7AChR interaction and represents a promising direction for further investigations and clinical development. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12035-020-02270-0.
format Online
Article
Text
id pubmed-8018932
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-80189322021-04-16 Modified Snake α-Neurotoxin Averts β-Amyloid Binding to α7 Nicotinic Acetylcholine Receptor and Reverses Cognitive Deficits in Alzheimer’s Disease Mice Fonar, Gennadiy Polis, Baruh Sams, Dev Sharan Levi, Almog Malka, Assaf Bal, Natalia Maltsev, Alexander Elliott, Evan Samson, Abraham O. Mol Neurobiol Article Alzheimer’s disease (AD) is the most common cause of senile dementia and one of the greatest medical, social, and economic challenges. According to a dominant theory, amyloid-β (Aβ) peptide is a key AD pathogenic factor. Aβ-soluble species interfere with synaptic functions, aggregate gradually, form plaques, and trigger neurodegeneration. The AD-associated pathology affects numerous systems, though the substantial loss of cholinergic neurons and α7 nicotinic receptors (α7AChR) is critical for the gradual cognitive decline. Aβ binds to α7AChR under various experimental settings; nevertheless, the functional significance of this interaction is ambiguous. Whereas the capability of low Aβ concentrations to activate α7AChR is functionally beneficial, extensive brain exposure to high Aβ concentrations diminishes α7AChR activity, contributes to the cholinergic deficits that characterize AD. Aβ and snake α-neurotoxins competitively bind to α7AChR. Accordingly, we designed a chemically modified α-cobratoxin (mToxin) to inhibit the interaction between Aβ and α7AChR. Subsequently, we examined mToxin in a set of original in silico, in vitro, ex vivo experiments, and in a murine AD model. We report that mToxin reversibly inhibits α7AChR, though it attenuates Aβ-induced synaptic transmission abnormalities, and upregulates pathways supporting long-term potentiation and reducing apoptosis. Remarkably, mToxin demonstrates no toxicity in brain slices and mice. Moreover, its chronic intracerebroventricular administration improves memory in AD-model animals. Our results point to unique mToxin neuroprotective properties, which might be tailored for the treatment of AD. Our methodology bridges the gaps in understanding Aβ-α7AChR interaction and represents a promising direction for further investigations and clinical development. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12035-020-02270-0. Springer US 2021-01-08 2021 /pmc/articles/PMC8018932/ /pubmed/33417228 http://dx.doi.org/10.1007/s12035-020-02270-0 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Fonar, Gennadiy
Polis, Baruh
Sams, Dev Sharan
Levi, Almog
Malka, Assaf
Bal, Natalia
Maltsev, Alexander
Elliott, Evan
Samson, Abraham O.
Modified Snake α-Neurotoxin Averts β-Amyloid Binding to α7 Nicotinic Acetylcholine Receptor and Reverses Cognitive Deficits in Alzheimer’s Disease Mice
title Modified Snake α-Neurotoxin Averts β-Amyloid Binding to α7 Nicotinic Acetylcholine Receptor and Reverses Cognitive Deficits in Alzheimer’s Disease Mice
title_full Modified Snake α-Neurotoxin Averts β-Amyloid Binding to α7 Nicotinic Acetylcholine Receptor and Reverses Cognitive Deficits in Alzheimer’s Disease Mice
title_fullStr Modified Snake α-Neurotoxin Averts β-Amyloid Binding to α7 Nicotinic Acetylcholine Receptor and Reverses Cognitive Deficits in Alzheimer’s Disease Mice
title_full_unstemmed Modified Snake α-Neurotoxin Averts β-Amyloid Binding to α7 Nicotinic Acetylcholine Receptor and Reverses Cognitive Deficits in Alzheimer’s Disease Mice
title_short Modified Snake α-Neurotoxin Averts β-Amyloid Binding to α7 Nicotinic Acetylcholine Receptor and Reverses Cognitive Deficits in Alzheimer’s Disease Mice
title_sort modified snake α-neurotoxin averts β-amyloid binding to α7 nicotinic acetylcholine receptor and reverses cognitive deficits in alzheimer’s disease mice
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018932/
https://www.ncbi.nlm.nih.gov/pubmed/33417228
http://dx.doi.org/10.1007/s12035-020-02270-0
work_keys_str_mv AT fonargennadiy modifiedsnakeaneurotoxinavertsbamyloidbindingtoa7nicotinicacetylcholinereceptorandreversescognitivedeficitsinalzheimersdiseasemice
AT polisbaruh modifiedsnakeaneurotoxinavertsbamyloidbindingtoa7nicotinicacetylcholinereceptorandreversescognitivedeficitsinalzheimersdiseasemice
AT samsdevsharan modifiedsnakeaneurotoxinavertsbamyloidbindingtoa7nicotinicacetylcholinereceptorandreversescognitivedeficitsinalzheimersdiseasemice
AT levialmog modifiedsnakeaneurotoxinavertsbamyloidbindingtoa7nicotinicacetylcholinereceptorandreversescognitivedeficitsinalzheimersdiseasemice
AT malkaassaf modifiedsnakeaneurotoxinavertsbamyloidbindingtoa7nicotinicacetylcholinereceptorandreversescognitivedeficitsinalzheimersdiseasemice
AT balnatalia modifiedsnakeaneurotoxinavertsbamyloidbindingtoa7nicotinicacetylcholinereceptorandreversescognitivedeficitsinalzheimersdiseasemice
AT maltsevalexander modifiedsnakeaneurotoxinavertsbamyloidbindingtoa7nicotinicacetylcholinereceptorandreversescognitivedeficitsinalzheimersdiseasemice
AT elliottevan modifiedsnakeaneurotoxinavertsbamyloidbindingtoa7nicotinicacetylcholinereceptorandreversescognitivedeficitsinalzheimersdiseasemice
AT samsonabrahamo modifiedsnakeaneurotoxinavertsbamyloidbindingtoa7nicotinicacetylcholinereceptorandreversescognitivedeficitsinalzheimersdiseasemice